QA: iBio Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420720_2017_iBio_Inc.pdf

Logs

Graph

Absolute values for 0001420720, iBio Inc.

  xvar xval
0 AssetsCurrent 23,906,000
1 IntangibleAssetsNetIncludingGoodwill 2,092,000
2 PropertyPlantAndEquipmentNet 25,574,000
3 remainder_Assets 28,000
4 LiabilitiesCurrent 2,291,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 25,265,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,685,000
9 ResearchAndDevelopmentExpense 3,156,000
10 remainder_Expenses 0
11 remainder_Revenues 948,000
12 remainder_NetIncome -764,000
13 remainder_ComprehensiveNetIncome -4,000
  yvar yval
0 Assets 51,600,000
1 Liabilities 27,556,000
2 Expenses 10,841,000
3 Revenues 948,000
4 StockholdersEquity 24,044,000
5 NetIncome -10,657,000
6 ComprehensiveNetIncome -10,659,000
7 BaseVar 45,856,500
8 EconomicCapitalRatio 0.776

Edgar->Model Mapping

Feature Distribution